Your browser doesn't support javascript.
loading
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo.
Dogo, F M; Ate, S; Agossou, K; Menon, S; Fiogbé, A A; Akpadja, K; Adjoh, S K; Veronese, V; Merle, C S; Koura, K G.
Afiliação
  • Dogo FM; National Tuberculosis Programme, Lomé, Togo;, International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Ate S; National Tuberculosis Programme, Lomé, Togo.
  • Agossou K; National Tuberculosis Programme, Lomé, Togo.
  • Menon S; International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Fiogbé AA; International Union Against Tuberculosis and Lung Disease, Paris, France;, National Tuberculosis Programme, Cotonou, Service de Pneumologie, Centre National et Universitaire de Pneumo-Phitsiologie de Cotonou (CNHUPP/C), Cotonou, Benin.
  • Akpadja K; National Tuberculosis Programme, Lomé, Togo.
  • Adjoh SK; Service de Pneumologie- Phitsiologie, Centre Hospitalier et Universitaire Sylvanus Olympio de Lomé, Lomé, Togo.
  • Veronese V; The Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.
  • Merle CS; The Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.
  • Koura KG; International Union Against Tuberculosis and Lung Disease, Paris, France;, COMUE (Communautés d'Universités et Établissements) Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris Descartes University, Paris, France.
Int J Tuberc Lung Dis ; 28(4): 195-201, 2024 04 01.
Article em En | MEDLINE | ID: mdl-38563340
ABSTRACT
In Togo, the COVID-19 pandemic paved the way for decentralising directly observed treatment (DOT) to the community level through the evaluation of two innovative community-based DOT approaches-a community health worker-based (CHW-DOT) and family-based (FB-DOT). METHODS We conducted an observational prospective study from April 2021 to January 2022. Sputum conversion at Month 2 and favourable treatment outcomes at Month 6 were assessed and compared between the two groups. Sociodemographic and clinical factors related to these outcomes were identified. RESULTS A total of 182 TB patients were enrolled. The CHW-DOT group had significantly increased odds of sputum conversion (aOR 2.95, 95% CI 1.09-7.98) and lower odds of unsuccessful treatment outcomes (aOR 0.37, 95% CI 0.13-1.1). Non-smokers had 4.85 higher odds of converting than smokers (aOR 4.85, 95% CI 1.76-13.42) and lower odds of an unsuccessful treatment than smokers (aOR 0.11, 95% CI 0.04-0.32). CONCLUSION CHW-DOT is associated with higher sputum smear conversion rates and a more favourable treatment outcome. The use of tobacco, significantly associated with outcomes, also suggests that a smoking cessation component may be a valuable adjunct to a CHW-DOT approach during TB treatment..
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article